ArticleScience (New York, N.Y.)2022
Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1.
Bridget S Gosis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
100 papers cite itlatest 60 shown
this papercites it